Imunon Inc (IMNN) Q4 2024 Earnings Call Highlights: Promising Advances Amid Financial Challenges
Imunon Inc (NASDAQ:IMNN) announced positive results from their phase 2 Ovation 2 study, showing significant improvement in ...
Q4 2024 Imunon Inc Earnings Call
Stacy Lindborg; Independent Director; Imunon Inc. Presentation. Operator. Good morning. My name is Mike, and I will be your operator today. At this time, I would lik ...
Hosted on MSN23h
Imunon reports immunogenicity and safety data from DNA plasmid vaccine trial
Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN ...
H.C. Wainwright Sticks to Their Hold Rating for Ventyx Biosciences (VTYX)
In a report released today, Emily Bodnar from H.C. Wainwright maintained a Hold rating on Ventyx Biosciences (VTYX – Research Report). The ...
Zacks Small Cap Research on MSN3h
IMNN: Phase 3 Ovarian Cancer Trial to get Underway in Mar 2025…
IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Phase 3 Ovarian Cancer Trial to Initiate in March 2025 Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial ...